The New England journal of medicine, 2022-09, Vol.387 (11), p.978-988
- Connolly, Stuart J.
- Karthikeyan, Ganesan
- Ntsekhe, Mpiko
- Haileamlak, Abraham
- El Sayed, Ahmed
- El Ghamrawy, Alaa
- Damasceno, Albertino
- Avezum, Alvaro
- Dans, Antonio M.L.
- Gitura, Bernard
- Hu, Dayi
- Kamanzi, Emmanuel R.
- Maklady, Fathi
- Fana, Golden
- Gonzalez-Hermosillo, J. Antonio
- Musuku, John
- Kazmi, Khawar
- Zühlke, Liesl
- Gondwe, Lillian
- Ma, Changsheng
- Paniagua, Maria
- Ogah, Okechukwu S.
- Molefe-Baikai, Onkabetse J.
- Lwabi, Peter
- Chillo, Pilly
- Sharma, Sanjib K.
- Cabral, Tantchou T.J.
- Tarhuni, Wadea M.
- Benz, Alexander
- van Eikels, Martin
- Krol, Amy
- Pattath, Divya
- Balasubramanian, Kumar
- Rangarajan, Sumathy
- Ramasundarahettige, Chinthanie
- Mayosi, Bongani
- Yusuf, Salim
2022
Details
- Autor(en) / Beteiligte
- Connolly, Stuart J.
- Karthikeyan, Ganesan
- Ntsekhe, Mpiko
- Haileamlak, Abraham
- El Sayed, Ahmed
- El Ghamrawy, Alaa
- Damasceno, Albertino
- Avezum, Alvaro
- Dans, Antonio M.L.
- Gitura, Bernard
- Hu, Dayi
- Kamanzi, Emmanuel R.
- Maklady, Fathi
- Fana, Golden
- Gonzalez-Hermosillo, J. Antonio
- Musuku, John
- Kazmi, Khawar
- Zühlke, Liesl
- Gondwe, Lillian
- Ma, Changsheng
- Paniagua, Maria
- Ogah, Okechukwu S.
- Molefe-Baikai, Onkabetse J.
- Lwabi, Peter
- Chillo, Pilly
- Sharma, Sanjib K.
- Cabral, Tantchou T.J.
- Tarhuni, Wadea M.
- Benz, Alexander
- van Eikels, Martin
- Krol, Amy
- Pattath, Divya
- Balasubramanian, Kumar
- Rangarajan, Sumathy
- Ramasundarahettige, Chinthanie
- Mayosi, Bongani
- Yusuf, Salim
- Titel
- Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation
- Ist Teil von
- The New England journal of medicine, 2022-09, Vol.387 (11), p.978-988
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2022
- Link zum Volltext
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Among patients with rheumatic heart disease and atrial fibrillation who received a vitamin K antagonist or rivaroxaban, the rate of stroke, systemic embolism, MI, or death from vascular or unknown causes was lower with a VKA, without increased bleeding.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2209051Titel-ID: cdi_proquest_journals_2714739599
- Format
- –
- Schlagworte
- Allergy, Anticoagulants, Anticoagulants - adverse effects, Anticoagulants - therapeutic use, Anticoagulation, Arrhythmias, Atrial fibrillation, Atrial Fibrillation - drug therapy, Atrial Fibrillation - etiology, Autoimmune Disease, Bacterial Infections, Bleeding, Blood clots, Cardiac arrhythmia, Cardiology, Cardiovascular disease, Cerebral infarction, Clinical trials, Comorbidity, Coronary artery disease, Creatinine, Death, Defibrillators, Disease prevention, Drug therapy, Echocardiography, Embolism, Embolisms, Factor Xa Inhibitors - adverse effects, Factor Xa Inhibitors - therapeutic use, Female, Fibrillation, Global Health, Health aspects, Heart attacks, Heart diseases, Hemorrhage - chemically induced, Hemostasis, Humans, Immunology, Infectious Disease, Inflammatory Disease, Low income groups, Male, Medical research, Middle Aged, Myocardial infarction, Pacemakers, Patient outcomes, Patients, Rheumatic heart disease, Rheumatic Heart Disease - complications, Rheumatic Heart Disease - diagnosis, Rheumatic Heart Disease - diagnostic imaging, Rheumatology, Rivaroxaban, Rivaroxaban - adverse effects, Rivaroxaban - therapeutic use, Stroke, Stroke - etiology, Stroke - prevention & control, Survival, Testing, Thromboembolism, Thrombosis, Treatment Outcome, Valvular Heart Disease, Vitamin K, Vitamin K - antagonists & inhibitors, Warfarin - adverse effects, Warfarin - therapeutic use